Effect of 3-thiadicarboxylic acid on lipid metabolism in experimental nephrosis.
- 1 November 1993
- journal article
- abstracts
- Published by Wolters Kluwer Health in Arteriosclerosis and Thrombosis: A Journal of Vascular Biology
- Vol. 13 (11) , 1580-1586
- https://doi.org/10.1161/01.atv.13.11.1580
Abstract
The effect of the sulfur-substituted fatty acid analogue 1,10 bis(carboxymethylthio)decane, also known as 3-thiadicarboxylic acid, on puromycin aminonucleoside-induced nephrotic hyperlipidemia was studied in rats. Treatment with 3-thiadicarboxylic acid (250 mg/kg) for 5 days reduced plasma levels of triglycerides from 5.8 to 2.7 mmol/L and cholesterol from 11.0 to 7.7 mmol/L. This was accounted for by decreases in very-low-density lipoprotein triglycerides, very-low-density lipoprotein cholesterol, and low-density lipoprotein cholesterol, without any major changes in the composition of plasma lipoproteins. The activities of two enzymes involved in fatty acid synthesis (ATP:citrate lyase and fatty acid synthetase) were inhibited by 3-thiadicarboxylic acid treatment, whereas acetyl-coenzyme A carboxylase activity was unchanged. In contrast, treatment with the sulfur-substituted fatty acid analogue induced the peroxisomal beta-oxidation of fatty acids ninefold and the mitochondrial beta-oxidation by 54% to 73%, depending on the substrate used. This was accompanied by a 26% reduction in hepatic triglyceride secretion rate. The hepatic phosphatidate phosphohydrolase activity was unchanged. 3-Thiadicarboxylic acid treatment suppressed the activity of the rate-limiting enzyme in cholesterol biosynthesis, 3-hydroxy-3-methylglutaryl-coenzyme A reductase, by 58%, whereas hepatic LDL receptor expression was unaltered. The activities of lipoprotein lipase and hepatic lipase were unchanged by treatment. These results demonstrated that treatment with 3-thiadicarboxylic acid ameliorates hyperlipidemia in experimental nephrosis primarily by decreasing the overproduction of very-low-density lipoprotein present. The data also indicate that hepatic very-low-density lipoprotein synthesis and secretion is strongly influenced by the availability of the fatty acid substrate under the same hyperlipidemic conditions.Keywords
This publication has 41 references indexed in Scilit:
- Rapid stimulation of liver palmitoyl-CoA synthetase, carnitine palmitoyltransferase and glycerophosphate acyltransferase compared to peroxisomal β-oxidation and palmitoyl-CoA hydrolase in rats fed high-fat dietsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1988
- Lovastatin therapy in nephrotic hyperlipidemia: Effects on lipoprotein metabolismKidney International, 1988
- Modification of fatty acid composition of membrane phospholipid in hepatocyte monolayer with n − 3, n − 6 and n − 9 fatty acids and its relationship to triacylglycerol productionBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1987
- Hepatic Secretion of Lipoproteins in the Rat and the Effect of Experimental NephrosisJournal of Clinical Investigation, 1979
- A selective decrease in mitochondrial glycerol phosphate acyltransferase activity in livers from streptozotocin‐diabetic ratsFEBS Letters, 1977
- HYPERLIPOPROTEINÆMIAS IN NEPHROTIC SYNDROMEThe Lancet, 1971
- The acylation of glycerophosphate in rat liver A new assay procedure for glycerophosphate acylation, studies on its subcellular and submitochondrial localization and determination of the reaction productsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1970
- ISCHÆMIC HEART-DISEASE COMPLICATING NEPHROTIC SYNDROMEThe Lancet, 1969
- ISCHIEMIC HEART-DISEASE AS A COMPLICATION OF NEPHROTIC SYNDROMEThe Lancet, 1969
- Studies on the turnover of triglyceride and esterified cholesterol in subjects with the nephrotic syndromeJournal of Clinical Investigation, 1968